S&P Downgrades AbbVie (ABBV) to 'A-' Amid Move to Acquire Stemcentrx; Outlook Stable

Go back to S&P Downgrades AbbVie (ABBV) to 'A-' Amid Move to Acquire Stemcentrx; Outlook Stable
AbbVie (NYSE: ABBV) Delayed: 108.50 -0.64 (0.59%)
Previous Close $109.14    52 Week High $68.12 
Open $109.08    52 Week Low $50.71 
Day High $109.14    P/E 23.54 
Day Low $107.79    EPS $4.61 
Volume 5,680,483